Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: A Japan Esophageal Oncology Group (JEOG) trial (JCOG9407)

Japanese Journal of Clinical Oncology

Volumn 31, Issue 9, 2001, Pages 419-423

  Hayashi, Kazuhiko ^a   Ando, Nobutoshi ^b   Watanabe, Hiroshi ^c   Ide, Hiroko ^a   Nagai, Kagami ^d   Aoyama, Norio ^e   Takiyama, Wataru ^f   Ishida, Kaoru ^g   Isono, Kaichi ^h   Makuuchi, Hiroyasu ⁱ   Imamura, Masayuki ^j   Shinoda, Masayuki ^k   Ikeuchi, Shunnji ^l   Kabuto, Toshiyuki ^m   Yamana, Hideaki ⁿ   Fukuda, Haruhiko ^o  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e KANAGAWA CANCER CENTER   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^g IWATE MEDICAL UNIVERSITY   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ TOKAI UNIVERSITY   (Japan)

^j KYOTO UNIVERSITY   (Japan)

^k AICHI CANCER CENTER HOSPITAL   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^m OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

ⁿ KURUME UNIVERSITY   (Japan)

^o NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

more..

Author keywords

Chemotherapy; Cisplatin; Esophageal cancer; Phase II study

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOLOGY; HUMAN; JAPAN; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; ONCOLOGY; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA;

EID: 20244364497     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hye090     Document Type: Article

References (18)

1. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma
2. Radical lymph node dissection for cancer of the thoracic esophagus
3. How extensive should lymph node dissection be for cancer of the thoracic esophagus?
4. Phase II evaluation of cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japan Esophageal Oncology Group Trial
5. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: Japan Esophageal Oncology Group Trial
6. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer
7. Preoperative chemotherapy, surgical resection and selective post-operative therapy for squamous cell carcinoma of the esophagus
8. Prolonged chemotherapy for localized squamous cell carcinoma of the esophagus
9. The effect of cis-diamminedichloroplatinum(II) on cultured human lymphoma cells and its therapeutic implications
10. Toxicity and response criteria of the Eastern Cooperative Oncology Group
11. Survival analysis
12. Toxicity grading criteria of the Japan Clinical Oncology Group
13. Design and analysis of clinical trials
14. Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin
15. Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: A comparative study of three different schedules of cisplatin administration
16. Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer
17. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
18. Phase II study of protracted infusional 5-fluorouracil combined with cisplatin for advanced gastric cancer